13F Data
13F filer · CIK 1431431

CLARUS VENTURES, LLC

CAMBRIDGE, MA · filing since Q4 2013 · last filing Nov 14, 2025
Reported value
$425.5M
+$144.3M vs prior
Positions
10
New / sold out
2 / 0
Added / reduced
1 / 0
Turnover
0.0%
buys $55.6M · sells $0
Top-10 weight
100.0%

Biggest buys vs Q2 2018

ChangeSecurityShares changeChange %Est. trade value
NewGritstone Oncology Inc+2,567,445–+$36.6M
NewEntasis Therapeutics Holdings Inc+1,623,405–+$17.7M
AddedNanostring Technologies Inc.+76,585+1.9%+$1.4M

Biggest sells vs Q2 2018

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $353.9MQ1 2014: $345.6MQ2 2014: $281.7MQ3 2014: $250.6MQ4 2014: $350.3MQ1 2015: $240.5MQ2 2015: $227.4MQ3 2015: $173.9MQ4 2015: $142.7MQ1 2016: $133.2MQ2 2016: $114.3MQ3 2016: $162.7MQ4 2016: $151.8MQ1 2017: $134.4MQ2 2017: $108.8MQ3 2017: $122.8MQ4 2017: $100.5MQ1 2018: $97.8MQ2 2018: $281.2MQ3 2018: $425.5M
Q4 2013Q3 2018

Holdings · Q3 2018

#SecuritySharesValueWeight
1AvroBio Inc.COM2,962,325$153.7M36.11%
2Nanostring Technologies Inc.COM4,036,025$72.0M16.91%
3Sientra Inc.COM2,730,765$65.2M15.33%
4Forty Seven IncCOM3,816,951$56.9M13.38%
5Gritstone Oncology IncCOM2,567,445$36.6M8.59%
6Entasis Therapeutics Holdings IncCOM1,623,405$17.7M4.15%
7Restoration Robotics Inc.COM3,569,986$10.4M2.43%
8VBI Vaccines Inc.COM2,691,042$6.5M1.53%
9ESSA Pharma Inc.COM1,668,560$5.0M1.18%
10Catabasis Pharmaceuticals Inc.COM2,008,192$1.6M0.38%